Akelos
New York, US · Founded 2018 · Delaware corporation
Founders & leadership
SF
Steven FoxExecutive
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 4 rounds · 2018–2026
▶$1.5MraisedMar 2026 · 81 investors · BiotechnologyRule 506(c)
▶$1.5MraisedMar 2026 · 81 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Steven FoxExecutive Officer
- Amount sold
- $1.5M
- Minimum investment
- $13.8K
- Finders' fees
- $3K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$5.5KraisedOct 2022 · 1 investors · BiotechnologyRule 506(c)
▶$5.5KraisedOct 2022 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Steven FoxExecutive Officer, Director
- Offering amount
- $14M
- Amount sold
- $5.5K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06c
▶$25KraisedFeb 2019 · 1 investors · BiotechnologyRule 506(b)
▶$25KraisedFeb 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven FoxExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $25K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$295KraisedNov 2018 · 12 investors · BiotechnologyRule 506(b)
▶$295KraisedNov 2018 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven FoxExecutive Officer, Director
- Offering amount
- $295K
- Amount sold
- $295K
- Proceeds to insiders
- $29.2K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Akelos raised?
- Akelos has disclosed $1.8M raised across 4 rounds.
- Where is Akelos headquartered?
- Akelos is headquartered in New York, US.